Overall Market Denials vs. Endocrinology
RemitDATA, in partnership with Physicians Practice magazine, delivers analysis of medical claims data and denial trends for the physician practice market.
The analysis generates a list of the top five denial codes across the entire market and also for a particular specialty. This month focuses on Endocrinology.
Endocrinology and the overall market rankings for March and April 2015 share three of the top five denied procedure codes.
Procedure codes 82962 (Glucose blood test) and 83036 (Glycosylated hemoglobin test) appear only on the Endocrinology top-five list. These are high-volume procedures for Endocrinology practices. Uncovering the reasons behind these denials is important and resolving the denials can help a practice reduce their denials and improve their cash flow.
Endocrinology: Comparison of 2014 and 2015 Data
Last year, RemitDATA performed a similar analysis on the endocrinology specialty using June 2014 claims data. The top-five lists for the 2014 and 2015 analyses are similar; however, there were two notable differences:
- In the 2015 analysis, procedure code 82962 (glucose blood test) ranked as the third most commonly unexpected denied procedure, yet that code was absent in the 2014 top-five list.
- Reason code 96 (non-covered charge) ranked fifth in the 2014 analysis, but was replaced by reason code 29 (time limit expired) in the fifth spot on the 2015 analysis.
View the Infographic
A detailed infographic of this information can be viewed at the Physicians Practice website, which partners with RemitDATA to publish the top-five lists.
Let Us Know How We Can Help You
If your organization is looking to optimize its revenue cycle processes, contact us to get a demonstration of our solutions.